US Stock MarketDetailed Quotes

GRCE Grace Therapeutics

Watchlist

3.390
+0.110+3.35%

Trading Nov 25 11:17 ET

34.37MMarket Cap-3725P/E (TTM)

Grace Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Sep 30, 2024

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

(Q2)Sep 30, 2023

(Q1)Jun 30, 2023

(FY)Mar 31, 2023

(Q4)Mar 31, 2023

(Q3)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-100.57%-4.24M

42.36%-3.6M

22.50%-12.33M

37.22%-2.09M

49.17%-1.89M

38.56%-2.11M

-15.00%-6.24M

7.67%-15.91M

-5.76%-3.33M

18.80%-3.72M

Net income from continuing operations

-4.86%-3.43M

34.95%-2.62M

69.71%-12.85M

89.12%-3.17M

38.52%-2.39M

33.60%-3.27M

11.07%-4.02M

-332.11%-42.43M

-645.06%-29.09M

-2.94%-3.89M

Operating gains losses

---361K

---1.4M

7,864.71%2.71M

1,379.17%1.07M

-786.96%-158K

----

100.61%34K

129.88%72K

102.78%23K

Depreciation and amortization

0.00%2K

-85.71%1K

-91.13%11K

-87.50%1K

-90.00%1K

103.28%2K

-95.81%7K

--124K

--8K

--10K

Deferred tax

-91.03%-852K

-150.52%-724K

80.80%-1.83M

89.98%-889K

24.09%-208K

-187.74%-446K

-19.42%-289K

-1,372.53%-9.54M

-1,268.98%-8.87M

---274K

Other non cash items

----

--1K

----

Change In working capital

143.75%203K

144.42%900K

-807.18%-1.28M

99.43%704K

1,545.71%506K

-140.92%-464K

-59.40%-2.03M

106.50%181K

-65.79%353K

94.88%-35K

-Change in receivables

---19K

1,031.43%326K

126.49%80K

797.06%237K

-234.07%-122K

--0

91.94%-35K

-1,577.78%-302K

89.03%-34K

-84.28%91K

-Change in prepaid assets

74.70%145K

35.92%-339K

337.50%315K

16.30%528K

-27.64%233K

-38.52%83K

36.95%-529K

118.95%72K

-59.72%454K

-2.72%322K

-Change in payables and accrued expense

114.34%77K

163.01%913K

-501.95%-1.65M

8.96%-61K

188.17%395K

-158.12%-537K

-72,550.00%-1.45M

117.21%411K

-131.16%-67K

71.88%-448K

-Change in other current assets

--0

---23K

--0

---10K

---13K

--0

Cash from discontinued investing activities

Operating cash flow

-100.62%-4.24M

42.37%-3.6M

22.50%-12.33M

37.22%-2.09M

49.17%-1.89M

38.56%-2.11M

-15.00%-6.24M

7.67%-15.91M

-5.76%-3.33M

18.80%-3.72M

Investing cash flow

Cash flow from continuing investing activities

-15K

-99.21%104K

31.17%6.55M

-31.05%-6.55M

214.58%110K

473.45%13.15M

45,281.82%4.99M

-997.85%-5M

Net PPE purchase and sale

----

623.53%89K

-162.50%-21K

--0

----

---17K

---8K

--0

Net investment purchase and sale

--0

---15K

-99.89%15K

31.38%6.57M

-31.05%-6.55M

--0

473.94%13.17M

45,354.55%5M

-997.85%-5M

Cash from discontinued investing activities

Investing cash flow

--0

---15K

-99.21%104K

31.17%6.55M

-31.05%-6.55M

214.58%110K

--0

473.45%13.15M

45,281.82%4.99M

-997.85%-5M

Financing cash flow

Cash flow from continuing financing activities

2,320.72%7.36M

304K

Net common stock issuance

----

2,313.82%7.34M

--0

----

--304K

--0

Proceeds from stock option exercised by employees

----

--21K

--0

----

--0

----

Cash from discontinued financing activities

Financing cash flow

----

2,320.72%7.36M

--0

----

--304K

--0

Net cash flow

Beginning cash position

-10.35%19.39M

-17.47%23.01M

-8.12%27.88M

-29.33%18.55M

-22.72%26.99M

-43.63%21.63M

-8.12%27.88M

-40.44%30.34M

-20.51%26.24M

-5.42%34.93M

Current changes in cash

-179.14%-4.24M

42.13%-3.61M

-98.29%-4.87M

167.71%4.46M

3.18%-8.45M

256.33%5.36M

-177.74%-6.24M

88.17%-2.46M

153.16%1.67M

-116.61%-8.72M

Effect of exchange rate changes

----

--0

----

-118.18%-2K

-105.23%-8K

-106.96%-32K

-65.77%38K

End cash Position

-43.85%15.16M

-10.35%19.39M

-17.47%23.01M

-29.33%18.55M

-22.72%26.99M

-43.63%21.63M

-8.12%27.88M

-20.51%26.24M

Free cash flow

-100.62%-4.24M

42.37%-3.6M

22.44%-12.36M

36.71%-2.11M

49.17%-1.89M

38.59%-2.11M

-14.85%-6.24M

7.57%-15.93M

-6.01%-3.33M

18.80%-3.72M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Sep 30, 2024	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023	(Q2)Sep 30, 2023	(Q1)Jun 30, 2023	(FY)Mar 31, 2023	(Q4)Mar 31, 2023	(Q3)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-100.57%-4.24M	42.36%-3.6M	22.50%-12.33M	37.22%-2.09M	49.17%-1.89M	38.56%-2.11M	-15.00%-6.24M	7.67%-15.91M	-5.76%-3.33M	18.80%-3.72M
Net income from continuing operations	-4.86%-3.43M	34.95%-2.62M	69.71%-12.85M	89.12%-3.17M	38.52%-2.39M	33.60%-3.27M	11.07%-4.02M	-332.11%-42.43M	-645.06%-29.09M	-2.94%-3.89M
Operating gains losses	---361K	---1.4M	7,864.71%2.71M	1,379.17%1.07M	-786.96%-158K	----	----	100.61%34K	129.88%72K	102.78%23K
Depreciation and amortization	0.00%2K	-85.71%1K	-91.13%11K	-87.50%1K	-90.00%1K	103.28%2K	-95.81%7K	--124K	--8K	--10K
Deferred tax	-91.03%-852K	-150.52%-724K	80.80%-1.83M	89.98%-889K	24.09%-208K	-187.74%-446K	-19.42%-289K	-1,372.53%-9.54M	-1,268.98%-8.87M	---274K
Other non cash items	----	--1K	----	----	----	----	----	----	----	----
Change In working capital	143.75%203K	144.42%900K	-807.18%-1.28M	99.43%704K	1,545.71%506K	-140.92%-464K	-59.40%-2.03M	106.50%181K	-65.79%353K	94.88%-35K
-Change in receivables	---19K	1,031.43%326K	126.49%80K	797.06%237K	-234.07%-122K	--0	91.94%-35K	-1,577.78%-302K	89.03%-34K	-84.28%91K
-Change in prepaid assets	74.70%145K	35.92%-339K	337.50%315K	16.30%528K	-27.64%233K	-38.52%83K	36.95%-529K	118.95%72K	-59.72%454K	-2.72%322K
-Change in payables and accrued expense	114.34%77K	163.01%913K	-501.95%-1.65M	8.96%-61K	188.17%395K	-158.12%-537K	-72,550.00%-1.45M	117.21%411K	-131.16%-67K	71.88%-448K
-Change in other current assets	--0	--0	---23K	--0	--0	---10K	---13K	--0	--0	--0
Cash from discontinued investing activities
Operating cash flow	-100.62%-4.24M	42.37%-3.6M	22.50%-12.33M	37.22%-2.09M	49.17%-1.89M	38.56%-2.11M	-15.00%-6.24M	7.67%-15.91M	-5.76%-3.33M	18.80%-3.72M
Investing cash flow
Cash flow from continuing investing activities	0	-15K	-99.21%104K	31.17%6.55M	-31.05%-6.55M	214.58%110K	0	473.45%13.15M	45,281.82%4.99M	-997.85%-5M
Net PPE purchase and sale	----	----	623.53%89K	-162.50%-21K	--0	----	----	---17K	---8K	--0
Net investment purchase and sale	--0	---15K	-99.89%15K	31.38%6.57M	-31.05%-6.55M	--0	--0	473.94%13.17M	45,354.55%5M	-997.85%-5M
Cash from discontinued investing activities
Investing cash flow	--0	---15K	-99.21%104K	31.17%6.55M	-31.05%-6.55M	214.58%110K	--0	473.45%13.15M	45,281.82%4.99M	-997.85%-5M
Financing cash flow
Cash flow from continuing financing activities			2,320.72%7.36M	0	0			304K	0	0
Net common stock issuance	----	----	2,313.82%7.34M	--0	--0	----	----	--304K	--0	--0
Proceeds from stock option exercised by employees	----	----	--21K	--0	--0	----	----	--0	--0	----
Cash from discontinued financing activities
Financing cash flow	----	----	2,320.72%7.36M	--0	--0	----	----	--304K	--0	--0
Net cash flow
Beginning cash position	-10.35%19.39M	-17.47%23.01M	-8.12%27.88M	-29.33%18.55M	-22.72%26.99M	-43.63%21.63M	-8.12%27.88M	-40.44%30.34M	-20.51%26.24M	-5.42%34.93M
Current changes in cash	-179.14%-4.24M	42.13%-3.61M	-98.29%-4.87M	167.71%4.46M	3.18%-8.45M	256.33%5.36M	-177.74%-6.24M	88.17%-2.46M	153.16%1.67M	-116.61%-8.72M
Effect of exchange rate changes	----	--0	--0	--0	----	----	-118.18%-2K	-105.23%-8K	-106.96%-32K	-65.77%38K
End cash Position	-43.85%15.16M	-10.35%19.39M	-17.47%23.01M	-17.47%23.01M	-29.33%18.55M	-22.72%26.99M	-43.63%21.63M	-8.12%27.88M	-8.12%27.88M	-20.51%26.24M
Free cash flow	-100.62%-4.24M	42.37%-3.6M	22.44%-12.36M	36.71%-2.11M	49.17%-1.89M	38.59%-2.11M	-14.85%-6.24M	7.57%-15.93M	-6.01%-3.33M	18.80%-3.72M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data